GLP-1 Muscle Loss — The Hidden Risk

GLP-1 Muscle Loss - The 40% Problem Your Doctor Might Not Mention

22 min · 7 de abr de 2026
Portada del episodio GLP-1 Muscle Loss - The 40% Problem Your Doctor Might Not Mention

Descripción

Host Ben Synth explores the hidden cost of GLP-1 medications like Ozempic and Wegovy: up to 40% of weight lost may be muscle, not fat. Drawing from real-world research and clinical trials, this episode examines muscle preservation strategies, including resistance training and protein-rich diets, as prescriptions surge 587% nationwide. Loved this episode? Discover more original shows from the Quiet Please Network at QuietPlease.ai, explore our curated favorites here amzn.to/42YoQGI, and catch just a slice of our AI hosts in action on Instagram at instagram.com/claredelish and YouTube at youtube.com/@DIYHOMEGARDENTV This content was created in partnership and with the help of Artificial Intelligence AI.

Comentarios

0

Sé la primera persona en comentar

¡Regístrate ahora y únete a la comunidad de GLP-1 Muscle Loss — The Hidden Risk!

Prueba gratis

Empieza 7 días de prueba

$99 / mes después de la prueba. · Cancela cuando quieras.

  • Podcasts solo en Podimo
  • 20 horas de audiolibros al mes
  • Podcast gratuitos

Todos los episodios

8 episodios

episode GLP-1 Muscle Loss — The Hidden Risk - Your Survival Guide for Protecting Muscle on Ozempic artwork

GLP-1 Muscle Loss — The Hidden Risk - Your Survival Guide for Protecting Muscle on Ozempic

Host Ben Synth examines research showing two-thirds of GLP-1 weight loss can be muscle, not fat. This episode covers evidence-based strategies to preserve muscle during Ozempic, Wegovy, or Mounjaro treatment: resistance training protocols, protein timing, hydration, and multidisciplinary care. Learn why exercise prevents weight regain after stopping medication. Loved this episode? Discover more original shows from the Quiet Please Network at QuietPlease.ai, explore our curated favorites here amzn.to/42YoQGI, and catch just a slice of our AI hosts in action on Instagram at instagram.com/claredelish and YouTube at youtube.com/@DIYHOMEGARDENTV This content was created in partnership and with the help of Artificial Intelligence AI.

7 de abr de 202625 min
episode GLP-1 Muscle Loss — The Hidden Risk - The Race to Build a Better Drug artwork

GLP-1 Muscle Loss — The Hidden Risk - The Race to Build a Better Drug

Host Ben Synth explores groundbreaking research on GLP-1 weight loss drugs and muscle preservation. He examines the BELIEVE study combining semaglutide with bimagrumab, which achieved 92.8% fat loss versus lean tissue loss, and discusses revolutionary continuous biosensor technology tracking muscle breakdown in real-time for patients on medications like Ozempic and Mounjaro. Loved this episode? Discover more original shows from the Quiet Please Network at QuietPlease.ai, explore our curated favorites here amzn.to/42YoQGI, and catch just a slice of our AI hosts in action on Instagram at instagram.com/claredelish and YouTube at youtube.com/@DIYHOMEGARDENTV This content was created in partnership and with the help of Artificial Intelligence AI.

7 de abr de 202624 min
episode GLP-1 Muscle Loss — The Hidden Risk - Uncover what your medication isn't telling you with Dr. Ben Synth artwork

GLP-1 Muscle Loss — The Hidden Risk - Uncover what your medication isn't telling you with Dr. Ben Synth

Join Dr. Ben Synth as he uncovers the hidden truth behind GLP-1 weight loss drugs: you're not just losing fat, you're losing muscle. This eye-opening series reveals the science pharmaceutical companies don't advertise and breakthrough strategies involving protein optimization, training protocols, and futuristic therapies that could revolutionize sustainable weight loss. Loved this episode? Discover more original shows from the Quiet Please Network at QuietPlease.ai, explore our curated favorites here amzn.to/42YoQGI, and catch just a slice of our AI hosts in action on Instagram at instagram.com/claredelish and YouTube at youtube.com/@DIYHOMEGARDENTV This content was created in partnership and with the help of Artificial Intelligence AI.

7 de abr de 202634 s